Skip to content
Screener

AbbVie ABBV Price / earnings

Price / earnings at other companies

Eli Lilly logo
Eli LillyLLY
40×-10.6×
Pfizer logo
PfizerPFE
14.7×
Johnson & Johnson logo
Johnson & JohnsonJNJ
29.1×+12.9×
Amgen logo
AmgenAMGN
22.4×-0.2×
Cardinal Health logo
Cardinal HealthCAH
32×+10.6×
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
28.6×

Other financials

Income statement

See full
Revenue$17.0B+10.2%
Gross profit$12.7B+14.6%
Operating income$6.4B+31.4%
Net income$3.6B+285%
EPS (diluted)$2.03+290%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$435.06B+25.5%
P/S6.8×+0.8×

Profitability

See full
Gross margin71.5%+0.5pp
Operating margin26.2%
Net margin9.8%+3.3pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Calculated from AbbVie’s reported figures.

Based on the most recent quarter.

The source filing: AbbVie’s 8-K, filed July 31, 2026. Open the filing →

Filed
Jul 31, 2026, 7:51 AM EDT
Accession
0001551152-26-000023

FAQ

What is AbbVie's price / earnings?
AbbVie (ABBV) reported price / earnings of 70.5× in Q2 2026.
How has AbbVie's price / earnings changed year-over-year?
AbbVie's price / earnings decreased by 19.1% year-over-year, from 87.1× to 70.5×.
What is the long-term trend for AbbVie's price / earnings?
Over 5 years (2020 to 2025), AbbVie's price / earnings has grown at a 18.4% compound annual growth rate (CAGR), from 41× to 95.6×.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Ask your AI about AbbVie's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude